Mary Flanagan Quinn

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

Edward A. Sausville, Patricia LoRusso, Michael A. Carducci et al. · Cancer Chemotherapy and Pharmacology · 2014 · 197 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

Jeffrey E. Lancet, Ivana Gojo, Michael Burton et al. · Leukemia · 2010 · 155 citations

Medicine, Pharmacology, Pharmacotherapy +13

Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors

Patricia LoRusso, Martin J. Edelman, S. Bever et al. · Journal of Clinical Oncology · 2012 · 94 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase I trial of the triplet M6620 (formerly VX970) + veliparib + cisplatin in patients with advanced solid tumors.

Geraldine O’Sullivan Coyne, Khanh Tu, Shivaani Kummar et al. · Journal of Clinical Oncology · 2018 · 12 citations

Life Sciences, Molecular Biology, Oncology +16

Phase I study of indenoisoquinolines LMP776 in adults with relapsed solid tumors and lymphomas.

Geraldine O’Sullivan Coyne, Shivaani Kummar, Robert Meehan et al. · Journal of Clinical Oncology · 2017 · 11 citations

Medicine, Oncology, Pharmacology +13